<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00706277</url>
  </required_header>
  <id_info>
    <org_study_id>2007-007161-25</org_study_id>
    <nct_id>NCT00706277</nct_id>
  </id_info>
  <brief_title>Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function</brief_title>
  <official_title>Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the effects of total intravenous anesthesia (TIVA;
      propofol, remifentanil) and balanced anesthesia (BAL; induction with propofol and fentanyl;
      maintenance of anesthesia with sevoflurane and nitrous oxide) on pulmonary function 30
      minutes after emergence from the general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FEV1 forced expiratory volume; FVC forced vital capacity</measure>
    <time_frame>preoperative, 30 minutes postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Function</condition>
  <arm_group>
    <arm_group_label>TIVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving total intravenous anesthesia (TIVA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>balanced</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving balanced anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol 2mg/kg for induction of anesthesia; followed by propofol 6 mg/kg/hour</description>
    <arm_group_label>TIVA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol 2mg</description>
    <arm_group_label>balanced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <description>remifentanil 0,25mcg/kg/hour</description>
    <arm_group_label>TIVA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <description>fentanyl 100mcg</description>
    <arm_group_label>balanced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane/Nitrous Oxide</intervention_name>
    <description>maintenance of anesthesia with sevoflurane and nitrous oxide</description>
    <arm_group_label>balanced</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1-2

          -  BMI normal

        Exclusion Criteria:

          -  lung disease

          -  Nicotine abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnulf Benzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TILAK Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TILAK Hospitals</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Gunnarsson L, Lindberg P, Tokics L, Thorstensson O, Th√∂rne A. Lung function after open versus laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 1995 Apr;39(3):302-6.</citation>
    <PMID>7793205</PMID>
  </reference>
  <reference>
    <citation>Regli A, von Ungern-Sternberg BS, Reber A, Schneider MC. Impact of spinal anaesthesia on peri-operative lung volumes in obese and morbidly obese female patients. Anaesthesia. 2006 Mar;61(3):215-21.</citation>
    <PMID>16480344</PMID>
  </reference>
  <reference>
    <citation>Natalini G, Franceschetti ME, Pletti C, Recupero D, Lanza G, Bernardini A. Impact of laryngeal mask airway and tracheal tube on pulmonary function during the early postoperative period. Acta Anaesthesiol Scand. 2002 May;46(5):525-8.</citation>
    <PMID>12027846</PMID>
  </reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2008</study_first_submitted>
  <study_first_submitted_qc>June 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2008</study_first_posted>
  <last_update_submitted>February 9, 2009</last_update_submitted>
  <last_update_submitted_qc>February 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Arnulf Benzer</name_title>
    <organization>TILAK A-6020 Innsbruck, Anichstr. 35 AUSTRIA</organization>
  </responsible_party>
  <keyword>forced vital capacity</keyword>
  <keyword>forced expired volume in 1 s</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

